Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

6

Revenue 2017

Johnson & Johnson

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Johnson & Johnson's 2013 sales performance.

Johnson & Johnson

Uncertainty, austerity and Brexit

Uncertainty, austerity and Brexit

Paul Johnson, Chief Economist at the respected Institute for Fiscal Studies, tweeted: “Growth forecasts dreadful compared with what we thought in March 2016, dreadful by historical standards and dreadful compared with

BenevolentAI raises $115m to fund drug development

BenevolentAI raises $115m to fund drug development The drug has been licensed from Johnson &Johnson (J&J), which was originally developing it for attention-deficit hyperactivity disorder (ADHD).

Research Partnership adds to its team

Research Partnership adds to its team With particular interest in the digital therapy and growing health-tech arena, Coffin brings experience from both agency and client side, holding roles for Roche and Johnson &Johnson.

Smith & Nephew name new CEO

Smith & Nephew name new CEO Prior to Alere, Nawana spent more than 15 years at Johnson &Johnson, primarily in its medical devices and diagnostics segment.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics